Home > Healthcare > Medical Devices > Diagnostic Devices > Respiratory Disease Testing Market
Respiratory Disease Testing Market Share
- Report ID: GMI1871
- Published Date: Apr 2023
- Report Format: PDF
Respiratory Disease Testing Market Share
Some of the leading players in the respiratory disease testing market include:
- Abbott
- Becton
- Dickinson and Company
- Koninklijke Philips N.V
- ResMed
- VYAIRE MEDICAL INC
- Fischer & Paykel, Medtronic
- BioMerieux SA
- CAREstream Medical Ltd
- Thermo Fischer Scientific
- Cosmed
- Seegene Inc
- SDI Diagnostics
- Siemens Healthineers.
Frequently Asked Questions (FAQ) :
Global market for respiratory disease testing reached USD 14 billion in 2022 and will exhibit 6.5% CAGR from 2023-2032 due to the growing number of government-led initiatives.
In vitro diagnostics tests will showcase more than 6% CAGR from 2023-2032 owing to their multiple advantages in the diagnosis and treatment of respiratory conditions.
The respiratory disease testing market in North America will record 6.4% CAGR from 2023-2032 on account of the strong presence of well-developed healthcare infrastructure in the region.
Abbott, Becton, Dickinson, and Company, Koninklijke Philips N.V., ResMed, VYAIRE MEDICAL, INC., Fischer & Paykel, Medtronic, BioMerieux SA, Cosmed, Seegene Inc., SDI Diagnostics, and Siemens Healthineers are the major market participants.
Respiratory Disease Testing Market Scope
×
Get a free sample of
Respiratory Disease Testing Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below